As of July 2015, Jorgen Willemsen has joined the CMC team of Treeway. He currently supports our CMC Project Leader and is involved in the entire CMC development trajectory from early development until market introduction.
Prior to joining Treeway, Jorgen worked at Corbion in Gorinchem, The Netherlands. During this period, he obtained broad knowledge in designing continuous chemical processes for the production of chemicals derived from biorenewables. Jorgen obtained his PhD in Organic Chemistry at the Radboud University in Nijmegen.
Manuela held different positions at GlaxoSmithKline BV, the Netherlands, for a period of ten years. During this period, she obtained broad knowledge in clinical research, project management, working in study teams and coaching.
Her main area of interest consisted of psychiatry and neurology. She worked on phase II-III and IV trials.She also participated in several research projects at the Radboud University Nijmegen. Manuela studied Clinical Psychology at the Radboud University in Nijmegen and obtained her Master of Science degree.
As of February 2015, Marie-José van Lierop has joined Treeway as a scientist to strengthen the scientific foundation of the R&D pipeline of Treeway.
Before joining Treeway she worked for 18 years within the pharmaceutical industry in The Netherlands at Organon/Schering Plough/Merck, 15 years of which as Senior Scientist Immunology in Drug Discovery. During this period she provided, both as a group and project leader, immunological and pharmacological research support in multidisciplinary global teams on various pre-clinical projects mainly focused on autoimmunity and inflammation.
For three years she obtained additional experience in clinical development as scientist in pharmacokinetics and pharmacodynamics.
Marie-José studied Molecular Sciences at the Agricultural University of Wageningen, the Netherlands and obtained her PhD degree in vaccine development at the faculty of Veterinary Medicine, University of Utrecht, the Netherlands.
Ellen joined Treeway as a Clinical Project Lead in December 2014. She has over 15 years of international pharmaceutical industry experience and a deep insight in preclinical and clinical drug development.
As a Global Clinical Pharmacology Lead for projects in early and late phases of development, she has extensive experience in designing and executing focused and innovative clinical development plans and in interacting with regulatory authorities in Europe, US and Japan.
Ellen studied Medical Biology at the University of Utrecht, the Netherlands, obtained her PhD at the department of Virology at the Erasmus University Rotterdam, the Netherlands, and was trained and as a certified Clinical Pharmacologist at the Centre for Human Drug Research in Leiden, the Netherlands.
Ramon worked for over 10 years in the pharmaceutical industry in The Netherlands at Organon/Schering-Plough/Merck-MSD.
During this period he gained experience in drug development, clinical pharmacokinetics, scientific writing and regulatory affairs, and participated in various multidisciplinary global project teams.
Ramon studied Polymer Chemistry and obtained his Bsc. at the Hogeschool Venlo, The Netherlands.
Dirk worked for 30 years in the pharmaceutical industry in The Netherlands at Organon N.V./Schering-Plough/Merck-MSD.
During this period he was the global regulatory affairs director for both early and late stage development projects in various therapeutic areas. In this position he gained extensive knowledge and experience in developing global regulatory strategies, and was involved in many interactions and meetings with international regulatory agencies, including EMA and FDA.
Dirk studied biology at the State University of Utrecht in The Netherlands, and gained his Ph.D. on Medical Sciences (thesis on spermatogonial stem cell kinetics).
Sytske held different positions at MSD, Schering-Plough, and N.V. Organon.
During this period, she obtained broad knowledge in formulation development and biopharmaceutics related topics, ranging from preclinical development up to the market formulation and including regulatory requirements.
She also has extensive experience in project leadership, working in and leading interdisciplinary teams (CMC, Toxicology, Clinical, Regulatory), and coaching.
Sytske studied Molecular Sciences at the Wageningen University. She obtained her PhD degree at the Faculty of Medical Sciences at the Radboud University Nijmegen.
François worked in the pharmaceutical industry for 10 years in various positions at Organon N.V., Schering-Plough and Merck.
During this time he gained broad experience and skills in leadership in drug discovery and development both as line- and project manager in the area of toxicology, DMPK, biopharmaceutics and early clinical research. His latest position at Merck was compound director non-clinical development.
François studied Biological Sciences at the University of Utrecht, The Netherlands and obtained his Ph.D. on Immunotoxicology at the faculty of Veterinary Medicine, Utrecht University in close collaboration with the National Institute for Public Health and the Environment (RIVM) in Bilthoven, The Netherlands.
Bert worked as project toxicologist at Organon N.V., which became Schering Plough and later on Merck, for 5 years. In this role, he gained broad experience in the non-clinical development of compounds for various indications, including small molecules, biologics and vaccines.
As a project toxicologist he participated in multilple scientific interactions with regulatory bodies. Bert is a European Registered Toxicologist.
Prior to joining the pharmaceutical industry Bert was senior non-clinical assessor for the Medicines Evaluation Board in The Netherlands for 8 years. In this role, he was involved in the non-clinical assessment of European Registration Dossiers, Clinical Trial Applications and Scientific Advice procedures.